Efficacy and Safety of Rituximab in Chinese Children With Refractory Anti-NMDAR Encephalitis

Purpose: To assess the efficacy and safety of rituximab treatment as second-line immunotherapy in pediatric cases of anti-NMDA receptor (NMDAR) encephalitis. Methods: We retrospectively recruited 8 patients with anti-NMDAR encephalitis who were treated with rituximab as second-line immunotherapy. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Dou, Xiangjun, Li, Dongjing, Wu, Yan, Wang, Zhijing, Yang, Le, Ma, Nan, Wang, Dong, Li, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767921/
https://www.ncbi.nlm.nih.gov/pubmed/33381080
http://dx.doi.org/10.3389/fneur.2020.606923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7767921/
https://www.ncbi.nlm.nih.gov/pubmed/33381080
http://dx.doi.org/10.3389/fneur.2020.606923

Ejemplares similares